BridgeMD
New treatment option for Anorexia Nervosa
Official title Discovering New Insights Into Anorexia Nervosa: Influence of MicrObial DysbiosiS (DIAMOnDS)
ClinicalTrials.gov ID: NCT06043154
What this study is testing
- What it's testing
- This study will investigate the link between the gut microbiota, the occurrence of the central adiposity phenotype, and the patients' fear to regain weight in anorexia nervosa.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 15 and older, women only
You may be able to join if
- Women
- Over 15 years old and 3 months.
- Admitted in the specialized department for eating disorders of CHU Nantes for refeeding.
- With a diagnosis of anorexia nervosa at admission (restrictive or Binge-Eating-Purging type).
- Body Mass Index at admission below 16 kilogram per square meter.
You likely can't join if
- Pregnant and breastfeeding women.
- Who received a treatment with antibiotic/antifungal (other than local application) in the last three months.
- Who had a weight gain in the last month (5% or more of the patient's weight at admission).
- Under trusteeship or guardianship.
- Not fluent in French
- Who participate in another treatment study involving medication.
See the full eligibility criteria
- Women
- Over 15 years old and 3 months.
- Admitted in the specialized department for eating disorders of CHU Nantes for refeeding.
- With a diagnosis of anorexia nervosa at admission (restrictive or Binge-Eating-Purging type).
- Body Mass Index at admission below 16 kilogram per square meter.
- Written informed consent for patients over 18 years old/ oral informed consent from both the patient and a legal representative for patients under 18 years old.
- Affiliated with French social security system or beneficiary from such system.
- Pregnant and breastfeeding women.
- Who received a treatment with antibiotic/antifungal (other than local application) in the last three months.
- Who had a weight gain in the last month (5% or more of the patient's weight at admission).
- Under trusteeship or guardianship.
- Not fluent in French
- Who participate in another treatment study involving medication.
- Patients for whom stool collection or body mass composition analysis (with Dual-energy X-ray absorptiometry) couldn't be done during the first week of hospitalisation.
The study team makes the final eligibility decision.
Where it's taking place
- Nantes, France
Compensation & support
Compensation mentioned.
ClinicalTrials.gov doesn't provide a reliable structured field for payment or travel support - confirm details with the study team.
Questions & answers
Do participants get paid in this trial?
This study's listing includes signals that participants may be compensated or receive a stipend. Amounts vary and are set by the study team - confirm the details with them.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling female, 15 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Nantes, France. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.